Advertisement

A Unifying Concept for Polycystic Ovary Syndrome

  • Rogerio A. Lobo
Part of the Serono Symposia USA book series (SERONOSYMP)

Abstract

In attempting to unify the concepts presented in this book, this chapter first discusses the nomenclature of the disorder and what the disorder should be called. In addition, a hypothesis is presented in an attempt to unify various concepts and reconcile the differences presented by the many investigators who have studied the disorder. While an in-depth discussion of pathophysiology is not possible, an overview of the major features possibly contributing to the disorder is presented.

Keywords

Luteinizing Hormone Polycystic Ovary Polycystic Ovary Syndrome Congenital Adrenal Hyperplasia Unify Concept 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992; 167: 1807–12.PubMedGoogle Scholar
  2. 2.
    Lobo RA. Polycystic ovary syndrome. In: Mishell DR Jr, Davajan V, eds. Infertility, contraception and reproductive endocrinology, 2nd ed. Oradell, NJ: Medical Economics Company, 1987: 319–36.Google Scholar
  3. 3.
    Lobo RA. A disorder without identity: “HCA,” “PCO,” “PCOD,” “PCOS,” “SLS.” What are we to call it? ! Fertil Steril 1995; 63: 1158–60.Google Scholar
  4. 4.
    Bridges NA, Cooke A, Healy MJR, Hindmarsh PC, Brook CGD. Standards for ovarian volume in childhood and puberty. Fertil Steril 1993; 60: 456–60.PubMedGoogle Scholar
  5. 5.
    Gadir AA, Khatim MS, Mowafi RS, Alnaser HMI, Muharib NS, Shaw RW. Implications of ultrasonically diagnosed polycystic ovaries. I. Correlations with basal hormonal profiles. Hum Reprod 1992; 7: 453–7.PubMedGoogle Scholar
  6. 6.
    Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries—a common finding in normal women. Lancet 1988; 1: 870–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Futterweit W, Deligdisch L. Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals. J Clin Endocrinol Metab 1986; 62: 16–21.PubMedCrossRefGoogle Scholar
  8. 8.
    Baien AH, Schachter ME, Montgomery D, Reid RW, Jacobs HS. Polycystic ovaries are a common finding in untreated female to male transsexuals. Clin Endocrinol 1993; 38: 325–9.CrossRefGoogle Scholar
  9. 9.
    Shoham Z, Conway GS, Patel A, Jacobs HS. Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril 1992; 58: 37–45.PubMedGoogle Scholar
  10. 10.
    Wong IL, Morris RS, Lobo RA, Paulson RJ, Sauer MV. Isolated polycystic morphology in ovum donors predicts response to ovarian stimulation. Hum Reprod 1995; 10: 524–8.PubMedGoogle Scholar
  11. 11.
    Mason HD, Willis DS, Beard RW, Winston RML, Margara R, Franks S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 1994; 79: 1355–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Jahanfar S, Eden JA, Warren P, Seppälä M, Nguyen TV. A twin study of polycystic ovary syndrome. Fertil Steril 1995; 63: 478–86.PubMedGoogle Scholar
  13. 13.
    Adams J, Poison DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293: 355–9.CrossRefGoogle Scholar
  14. 14.
    Lobo RA, Granger LR, Paul WL, Goebelsmann U, Mishell DR Jr. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol 1983; 145: 496–503.PubMedGoogle Scholar
  15. 15.
    Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. J Clin Endocrinol Metab 1988; 66: 131–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Carmina E, Stanczyk FZ, Lee PDK, Savjani G, Lobo RA. Altered regulation of insulin-like growth factor binding protein-1 in patients with polycystic ovary syndrome. J Soc Gynecol Invest 1995; 2: 743–7.CrossRefGoogle Scholar
  17. 17.
    Rosenfield RL, Barnes RB, Cara JF, Lucky AW. Dysregulation of cytochrome P450c17a as the cause of polycystic ovarian syndrome. Fertil Steril 1990; 53: 785–91.PubMedGoogle Scholar
  18. 18.
    Carey AH, Chan KL, Short F, White D, Williamson R, Franks S Evidence for a single gene effect of causing polycystic ovaries and male pattern baldness. Clin Endocrinol 1993; 38: 653–8.CrossRefGoogle Scholar
  19. 19.
    Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994; 3: 1873–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Ditkoff EC, Fruzzetti F, Chang L, Stanczyk FZ, Lobo RA. The impact of estrogen on adrenal androgen sensitivity and secretion in polycystic ovary syndrome. J Clin Endocrinol Metab 1995; 80: 603–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Barnes RB, Mileikowsky GN, Cha KY, Spencer CA, Lobo RA. Effects of dopamine and metoclopramide in polycystic ovary syndrome. J Clin Endocrinol Metab 1986; 63: 506–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Rosen GF, Lobo RA. Further evidence against dopamine deficiency as the cause of inappropriate gonadotropin secretion in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1987; 65: 891–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Legro RS, Dietz GW, Comings DE, Lobo RA, Kovacs BW. Association of dopamine D2 receptor gene haplotypes with anovulation and fecundity in female Hispanics. Hum Reprod 1994; 9: 1271–5.PubMedGoogle Scholar
  24. 24.
    Legro RS, Muhleman DR, Comings DE, Lobo RA, Kovacs BW. A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate. Fertil Steril 1995; 63: 779–84.PubMedGoogle Scholar
  25. 25.
    Lobo RA, Kletzky OA, Campeau JD, diZerega GS. Elevated bioactive luteinizing hormone in women with the polycystic ovary syndrome. Fertil Steril 1983; 39: 674–8.PubMedGoogle Scholar
  26. 26.
    Levin JH, Carmina E, Lobo RA. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult onset congenital adrenal hyperplasia? Fertil Steril 1991; 56: 635–40.PubMedGoogle Scholar
  27. 27.
    Carmina E, Wong IL, Thornton MH, Stanczyk FZ, Paulson RJ, Sauer MV, Lobo RA. Androgen profiles of ovulatory women with polycystic appearing ovaries and alterations in serum IGF-BP1. Presented at the 77th Annual Meeting of The Endocrine Society, June 14–17, 1995, Washington, DC.Google Scholar
  28. 28.
    Shoupe D, Lobo RA. Evidence for altered catecholamine metabolism in polycystic ovary syndrome. Am J Obstet Gynecol 1984; 150: 566–71.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Rogerio A. Lobo

There are no affiliations available

Personalised recommendations